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Prophylactic Nurturing of Antibiotic Resistance Genes
S. Soleimani-Connolly ∗, S.N. Connolly
University of Teesside, Middlesbrough, United Kingdom
Prophylaxis with the anti-staphylococcal antibiotic
mupirocin (Mup) introduced to Iran during 1995 led to the
rapid emergence of resistant strains. This study reports
that conjugative plasmids in coagulase negative staphy-
lococci (CNS) act as a reservoir of mupirocin resistance
(MupR) genes. The resistant elements are transferable to
pathogenic S. aureus strains leading to the dissemination of
resistance.
Staphylococci (1404 strains) were isolated from patients
attending a renal dialysis clinic over a period of 12 months
pre- and post-prophylactic application of Mup. Plasmid pro-
ﬁles & antibiograms of MupR strains were determined and
the resistance plasmids eliminated by curing. Conjugative
transfer of MupR involved ﬁlter mating to a reference
S. aureus strain. Pulsed ﬁeld gel electrophoresis (PFGE)
demonstrated the MupR plasmid. The MupR gene was cloned
into S. carnosus and a digoxigenin labeled 13.4 kb HindIII
fragment was used as a probe to screen other staphylococcal
isolates.
Staphylococcal strains consisting of S. epidermidis (1119)
and S. hominis (285) were isolated over a period of 14
months. Nasal decolonisation with Mup involved topical
application for 12 days. Eight high level resistance strains
(2000mg L−1) emerged within 4 months of clinical applica-
tion of the antibiotic. PFGE separated a large plasmid from
chromosomal DNA. Curing experiments conﬁrmed that this
plasmid was responsible for MupR as its elimination in the
cured strains rendered them Mup sensitive. High level MupR
was attributed to a 34 kb conjugative plasmid transferable
between CNS and S. aureus. The frequency of transfer was
of the order of 10−7 to 10−9. A 3.9 kb fragment of the MupR
plasmid hybridised to the probe DNA.
MupR develops during topical application of the antibiotic
and the transfer of the Mup gene occurs between CNS and
pathogenic staphylococci. This suggests that antibiotic pro-
phylaxis nurtures dormant genes thus leading to the spread
of resistance in non-endemic regions.
doi:10.1016/j.ijid.2008.05.1078
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teria Isolated from Burn Wounds and Comparison with
Effects of Selective Antibiotics in vitro
M.M. Attarpour Yazdi1,∗, M. Kamalinejad2
1 Shahed University(Faculty of Medicine), Tehran, Iran
(Islamic Republic of)
2 Shahid Beheshti University(Faculty of Pharmacy), Tehran,
Iran (Islamic Republic of)
Background: Burn wound is suitable site for incidence of
resistant infections. Thus, the research for ﬁnding of effec-
tive drugs against this problem is necessary. Medicinal herbs
with antimicrobial activity have been important role in tra-
ditional medicine. The purpose of this study was determine
of antibacterial activity of methanolic extract from fruit
of Terminalia catappa against bacteria isolated from burn
wound infections and comparison with effects of selective
antibiotics in vitro.
Methods: First, a sample of methanolic extract of the
plant fruit was prepared and then its antibacterial activity
against 8 cases of bacteria isolated from 100 samples of burn
wound infections was evaluated by well diffusion and agar
serial dilution methods for determining of MIC (minimum
inhibitory concentration). Also, we studied the activity of
selective antibiotics on them by disk diffusion method
Results: The frequency distribution tables, diagrams,
Kay square, ﬁsher exact and t test (by applying spss
computer programs) were used to describe and ana-
lyze the data. The results from the antibacterial tests
demonstrated that the T. catappa methanolic extract had
been effected against more than 80% of Staphylococ-
cus aureus/epidermidis/saprophyticus,Pseudomonas aerug-
inosa, Acinetobacter and against 50% E. coli. The MIC of the
extract against all the bacteria was 20mg/ml.
Conclusion: This study demonstrated that methanolic
extract of T. catappa have excellent antibacterial activity
against most of bacteria isolated from burn wound infec-
tions and its effect is more better than selective antibiotics.
However, we need more investigation in vitro and in vivo.
doi:10.1016/j.ijid.2008.05.1079
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An AUC Based Method for Aminoglycoside Dosing Adjust-
ing for Drug Excretion During Infusion and Allowing Early
Recognition of Drug Accumulation
M.R. Loewenthal
John Hunter Hospital, Newcastle, Australia
Background: Once daily aminoglycoside dosing is now
standard. Area Under the curve (AUC) is the best predic-
tor of bacterial killing and toxicity. Formulas or applications
based on two concentration measurements are widely used
to optimise the AUC. Published methods do not account for
excretion during the infusion which varies greatly with infu-
sion duration. Drug accumulation may not be apparent from
the AUC calculated after an initial inappropriately small
dose. Formulas simple enough to be put on any spreadsheet
application or handheld device were developed to deal with
these problems.
Methods: Excretion during infusion and the effect of
impaired excretion were restated as linear differential
equations which have standard solutions. These formulas
were then applied to a set of data used previously to dose
cystic ﬁbrosis inpatients based on published AUC formulas.
This allowed recalibration of the target value. This new tar-
get was then applied to simulated data (1) derived from
our database of cystic ﬁbrosis home therapy patients who
administer their doses over 5min and (2) for patients with
impaired renal function. The formulas are supplied on the
poster and can be freely used
Results: The target AUC was recalibrated from 110 to
100mgh/l. An estimated 50% of home therapy cystic ﬁbrosis
patients had initial AUCs more than 10% above the new tar-
get. This increased to 64% after dosage adjustment based on
